Raymond James & Associates’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $299K | Buy |
13,046
+1,769
| +16% | +$40.6K | ﹤0.01% | 3384 |
|
|
2024
Q2 | $326K | Sell |
11,277
-5,865
| -34% | -$169K | ﹤0.01% | 3305 |
|
|
2024
Q1 | $354K | Sell |
17,142
-94,604
| -85% | -$1.95M | ﹤0.01% | 3261 |
|
|
2023
Q4 | $3.02M | Sell |
111,746
-22,416
| -17% | -$606K | ﹤0.01% | 1833 |
|
|
2023
Q3 | $3.98M | Buy |
134,162
+9,770
| +8% | +$290K | ﹤0.01% | 1603 |
|
|
2023
Q2 | $4.45M | Sell |
124,392
-3,996
| -3% | -$143K | ﹤0.01% | 1553 |
|
|
2023
Q1 | $3.01M | Sell |
128,388
-3,076
| -2% | -$72.1K | ﹤0.01% | 1794 |
|
|
2022
Q4 | $3.58M | Sell |
131,464
-19,888
| -13% | -$541K | ﹤0.01% | 1649 |
|
|
2022
Q3 | $8.15M | Sell |
151,352
-6,572
| -4% | -$354K | 0.01% | 1072 |
|
|
2022
Q2 | $6.37M | Sell |
157,924
-7,817
| -5% | -$315K | 0.01% | 1244 |
|
|
2022
Q1 | $11M | Sell |
165,741
-25,254
| -13% | -$1.67M | 0.01% | 1013 |
|
|
2021
Q4 | $19.1M | Sell |
190,995
-8,772
| -4% | -$877K | 0.02% | 769 |
|
|
2021
Q3 | $25M | Buy |
199,767
+6,064
| +3% | +$758K | 0.02% | 594 |
|
|
2021
Q2 | $24.1M | Sell |
193,703
-3,177
| -2% | -$395K | 0.02% | 624 |
|
|
2021
Q1 | $30.1M | Sell |
196,880
-12,573
| -6% | -$1.92M | 0.03% | 484 |
|
|
2020
Q4 | $27M | Sell |
209,453
-1,956
| -0.9% | -$252K | 0.03% | 489 |
|
|
2020
Q3 | $23.6M | Sell |
211,409
-48,208
| -19% | -$5.39M | 0.03% | 475 |
|
|
2020
Q2 | $21.1M | Buy |
259,617
+3,918
| +2% | +$318K | 0.03% | 497 |
|
|
2020
Q1 | $17.8M | Buy |
255,699
+189,906
| +289% | +$13.2M | 0.03% | 498 |
|
|
2019
Q4 | $5.14M | Buy |
65,793
+12,423
| +23% | +$971K | 0.01% | 1224 |
|
|
2019
Q3 | $3.41M | Buy |
53,370
+461
| +0.9% | +$29.4K | ﹤0.01% | 1469 |
|
|
2019
Q2 | $4.57M | Buy |
52,909
+47,729
| +921% | +$4.12M | 0.01% | 1263 |
|
|
2019
Q1 | $397K | Buy |
+5,180
| New | +$397K | ﹤0.01% | 2805 |
|